Head-to-head comparisons of medication uses, side effects, warnings, and more.
Foundayo (orforglipron)
Rybelsus (semaglutide)
Foundayo (orforglipron)
Rybelsus (semaglutide)
Summary of Foundayo vs. Rybelsus
Summary for GLP-1 agonist
Prescription only
Foundayo (orforglipron) is an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It's approved for weight loss in certain adults. This medication is meant to be used together with a reduced-calorie diet and exercise. Foundayo (orforglipron) comes as tablets and is taken by mouth once a day with or without food. The dose is slowly raised over several weeks. Common side effects include nausea, constipation, and diarrhea.
Summary for GLP-1 agonist
Prescription only
Rybelsus (semaglutide) is a brand-name GLP-1 agonist that helps lower blood sugar in adults with Type 2 diabetes. It's also FDA approved to help reduce the risk of heart attack, stroke, and heart-related death in people with Type 2 diabetes who are at risk for these events. You take it as a pill once a day, at least 30 minutes before eating, drinking, or taking other medicatons by mouth. It’s used along with diet and exercise, and might also help with weight loss. Common side effects include nausea, stomach pain, and diarrhea.